Filing Details
- Accession Number:
- 0001209191-11-061815
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-16 17:08:23
- Reporting Period:
- 2011-12-16
- Filing Date:
- 2011-12-16
- Accepted Time:
- 2011-12-16 17:08:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1033188 | C John Aplin | 3000 Kent Ave, Suite A1-100 West Lafayette IN 47906 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-12-16 | 20,000 | $3.27 | 21,063 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.22 to $3.37, inclusive. The reporting person undertakes to provide Endoycte, Inc., any security holder of Endocyte, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This amount includes 693 shares of common stock distributed to Mr. Aplin from CID Equity Capital VIII, L.P. and 370 shares of common stock distributed to Mr. Aplin from CID Seed Fund, L.P. Mr. Aplin previously reported indirect ownership of the shares owned by these entities.
Billionaire Hedge Funds
